Cited by 431Gestational Diabetes Research and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Epidemiology and management of gestational diabetes

Open access
Sweeting, Arianne, Hannah, Wesley, Backman, Helena, Catalano, Patrick, Feghali, Maisa, Herman, Willliam H, Hivert, Marie-France, Immanuel, Jincy +8 more·2024·The Lancet

Abstract

Gestational diabetes is defined as hyperglycaemia first detected during pregnancy at glucose concentrations that are less than those of overt diabetes. Around 14% of pregnancies globally are affected by gestational diabetes; its prevalence varies with differences in risk factors and approaches to screening and diagnosis; and it is increasing in parallel with obesity and type 2 diabetes. Gestational diabetes direct costs are US$1·6 billion in the USA alone, largely due to complications including hypertensive disorders, preterm delivery, and neonatal metabolic and respiratory consequences. Between 30% and 70% of gestational diabetes is diagnosed in early pregnancy (ie, early gestational diabetes defined by hyperglycaemia before 20 weeks of gestation). Early gestational diabetes is associated with worse pregnancy outcomes compared with women diagnosed with late gestational diabetes (hyperglycaemia from 24 weeks to 28 weeks of gestation). Randomised controlled trials show benefits of treating gestational diabetes from 24 weeks to 28 weeks of gestation. The WHO 2013 recommendations for diagnosing gestational diabetes (one-step 75 gm 2-h oral glucose tolerance test at 24-28 weeks of gestation) are largely based on the Hyperglycemia and Adverse Pregnancy Outcomes Study, which confirmed the linear association between pregnancy complications and late-pregnancy maternal glycaemia: a phenomenon that has now also been shown in early pregnancy. Recently, the Treatment of Booking Gestational Diabetes Mellitus (TOBOGM) trial showed benefit in diagnosis and treatment of early gestational diabetes for women with risk factors. Given the diabesity epidemic, evidence for gestational diabetes heterogeneity by timing and subtype, and advances in technology, a life course precision medicine approach is urgently needed, using evidence-based prevention, diagnostic, and treatment strategies.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(24)00825-0

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Gupta Y, Simmons D. Can HbA1c have a crucial role in gestational diabetes? Lancet Diabetes Endocrinol (in press).
  2. Saravanan P, Deepa M, Ahmed Z, et al. Early pregnancy HbA1c as the first screening test for gestational diabetes: a prospective cohort study. Lancet Diabetes Endocrinol (in press).
  3. Burk J, Ross GP, Hernandez T, Colagiuri S, Sweeting A. Continuous glucose monitoring improves perinatal outcomes in women with diabetes in pregnancy: a systematic review. The 17th International Conference on Advanced Technologies & Treatments for Diabetes; March 6–9, 2024 (abstr).

Cited by

Sorted by citations

Authors
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., Nolan, C. J., Ram, U., Schmidt, M. I., Simmons, D., Chivese, T., & Benhalima, K.
Affiliations
  • The University of Sydney (AU)
  • Madras Diabetes Research Foundation (IN)
  • Tufts University (US)
  • University of Pittsburgh (US)
  • University of Michigan (US)
  • Harvard University (US)
  • Texas Woman's University (US)
  • Leicester General Hospital (GB)
  • Universidade Federal do Rio Grande do Sul (BR)
  • Australian National University (AU)
  • Seethapathy Clinic and Hospital (IN)
  • Western Sydney University (AU)
  • Qatar University (QA)
  • KU Leuven (BE)
Corresponding author
Simmons, David
Venue
The Lancet
Publisher
Elsevier BV
Published
2024-07
Volume
404
Issue
10448
Pages
175-192
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4399840978
Cited by
431
References
192
Citations by year
2026: 192 · 2025: 205 · 2024: 34
FWCI
203.51
Type
journal article
Language
en
Open access
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (acceptedVersion, other-oa)
  • Figshare (submittedVersion, cc-by)
  • ANU Open Research (Australian National University) (submittedVersion)
  • Qatar University QSpace (Qatar University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
gestational diabetes mellitus, gestational diabetes screening, oral glucose tolerance test, pregnancy complications, hypertensive disorders of pregnancy, preterm birth, neonatal outcomes, treatment timing, diabesity, type 2 diabetes, precision medicine
MeSH terms
Female, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy Outcome, Risk Factors, Prevalence, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review